The study was carried out in a village in Jessore district, Bangladesh, to
identify the epidemiological characteristics of arsenicosis. Eighty-seven p
er cent of the tubewells had arsenic concentration more than the WHO maximu
m permissible limit of 0.05 mg l(-1). The mean arsenic concentration was 0.
240 mg l(-1) and the maximum concentration was 1.371 mg l(-1). Of the total
3606 villagers, 10% (363) were found to be suffering from arsenicosis. Mos
t of the arsenicosis patients were between 10 to 39 years of age. There wer
e more male patients (52.6%). There were no patients among villagers who co
nsumed tubewell water having arsenic levels less than 0.082 mg l(-1). The m
ajority (93.4%) of the patients were in the first and second stage of arsen
icosis. With increasing exposure to arsenic, a simultaneous increase in the
severity of clinical manifestations of arsenicosis was observed (F=43.699;
p=0.000). The time-weighted arsenic exposure varied from 0.248 to 5.482 mg
day(-1) and the mean was 1.918 mg day(-1). Melanosis was present in almost
all the patient (99.5%) and keratosis was present in 68.9%. Cancer (basal
cell epithelioma) was present in three (0.8%) patients. The duration of cli
nical manifestations of arsenicosis varied from 1 to 12 years and the major
ity were suffering for 4-6 years.